More particularly, BMP signaling (non-canonical) is triggered by the overexpressed BMP2 and 4, promoting EAC (SMAD4-negative) aggressiveness; however, the inhibition of BMP2/4 via the VHHs limits tumor growth and increases survival [139]. Here, SMAD4 is linked to neoplasm.